tiprankstipranks
Trending News
More News >
Mira Pharmaceuticals enrolls first subjects in Phase 1 trial of Ketamir-2
PremiumThe FlyMira Pharmaceuticals enrolls first subjects in Phase 1 trial of Ketamir-2
26d ago
Mira Pharmaceuticals enrolls first subjects in Ketamir-2 trial
Premium
The Fly
Mira Pharmaceuticals enrolls first subjects in Ketamir-2 trial
26d ago
Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit
Premium
The Fly
Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit
1M ago
Psychedelic: MindMed reports Q4 earnings results
PremiumThe FlyPsychedelic: MindMed reports Q4 earnings results
2M ago
Mira Pharmaceuticals announces approval, initiation of Phase 1 Ketamir-2 trial
Premium
The Fly
Mira Pharmaceuticals announces approval, initiation of Phase 1 Ketamir-2 trial
2M ago
Rising High: Exclusive talk with pharmaceutical development company MIRA
Premium
The Fly
Rising High: Exclusive talk with pharmaceutical development company MIRA
3M ago
Mira Pharmaceuticals initiated with a Buy at Rodman & Renshaw
PremiumThe FlyMira Pharmaceuticals initiated with a Buy at Rodman & Renshaw
7M ago
Mira Pharmaceuticals presents preclinical data for Ketamir-2
Premium
The Fly
Mira Pharmaceuticals presents preclinical data for Ketamir-2
7M ago
Mira Pharmaceuticals advances Ketamir-2 development
Premium
The Fly
Mira Pharmaceuticals advances Ketamir-2 development
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100